Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 41,033 shares at $28.89 ($1.2M) on 2021-11-03, disclosed to the SEC on 2021-11-03.
Open-market sale of $1.2M ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 81 | $2K | 0.2% |
| 2 | $28.42 | 14,391 | $409K | 34.9% |
| 3 | $28.42 | 14,391 | $409K | 34.9% |
| 4 | $28.89 | 6,085 | $176K | 15.0% |
| 5 | $28.89 | 6,085 | $176K | 15.0% |
| Total | $28.56 avg | 41,033 |
| $1.2M |
| 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |